CRISPR/Cas9 Evolves into Multi-Tool: Expanding Applications from Leukemia Screening to CAR-T Cell Engineering and Epigenome Editing
NHSJS USA Overview CRISPR/Cas9 technology has significantly evolved, broadening its applications from screening leukemia mutations to enhancing CAR-T cells' cancer recognition and precisely controlling gene expression through epigenome e...
